Cargando…
ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells
5-FU-based combinatory chemotherapeutic regimens have been routinely used for many years for the treatment of breast cancer patients. Recurrence and chemotherapeutic drug resistance are two of the most prominent factors that underpin the high mortality rates associated with most breast cancers (BC)....
Autores principales: | Wang, Xuedong, Wang, Yueping, Gu, Juan, Zhou, Daoping, He, Zhimin, Wang, Xinhui, Ferrone, Soldano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575004/ https://www.ncbi.nlm.nih.gov/pubmed/28852196 http://dx.doi.org/10.1038/s41598-017-10468-x |
Ejemplares similares
-
Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP
por: Wang, Xuedong, et al.
Publicado: (2017) -
Long noncoding RNA CCAT2 reduces chemosensitivity to 5‐fluorouracil in breast cancer cells by activating the mTOR axis
por: Zhou, Daoping, et al.
Publicado: (2022) -
LINC00160 mediated paclitaxel‐And doxorubicin‐resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ
por: Wu, Huaiguo, et al.
Publicado: (2020) -
Long non‐coding RNA NEAT1 transported by extracellular vesicles contributes to breast cancer development by sponging microRNA-141-3p and regulating KLF12
por: Zhou, DaoPing, et al.
Publicado: (2021) -
Extracellular Vesicles Carrying miR-887-3p Promote Breast Cancer Cell Drug Resistance by Targeting BTBD7 and Activating the Notch1/Hes1 Signaling Pathway
por: Wang, Bing, et al.
Publicado: (2022)